World Pharmacy Drug Purchases In 1994

20 March 1995

North America and the UK were the fastest-growing drug markets in 1994, expanding by 8% to $52.9 billion and $5.6 billion respectively, according to new figures published by IMS International. This compares with selected world growth of 5% to $122.3 billion. The growth has been achieved despite public and private sector efforts to control health care costs in many countries across the globe.

The fastest-growing therapeutic sectors in the USA were central nervous system drugs (17%), cardiovascular drugs (16%) and alimentary and metabolism drugs (16%). Respiratory drugs also showed an 11% increase.

Overall, growth in the top seven markets in Europe was $46.9 billion, up 3% compared to 1993. The biggest growing category was cardiovascular drugs (up 22%), followed by alimentary/metabolism (18%), CNS (11%) and anti-infectives and respiratory agents (10%).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight